Search Results

Indisulam (E7070) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Indisulam (E7070) is a carbonic anhydrase inhbitor, is also a novel synthetic sulfon-amide that targets the G1 phase of the cell cycle.

More Information Supplier Page

Indisulam (E7070) 25mg 25mg  | Purity Not Available

Adooq Bioscience

Indisulam (E7070) is a carbonic anhydrase inhbitor, is also a novel synthetic sulfon-amide that targets the G1 phase of the cell cycle.

More Information Supplier Page

Indisulam (E7070) 100mg 100mg  | Purity Not Available

Adooq Bioscience

Indisulam (E7070) is a carbonic anhydrase inhbitor, is also a novel synthetic sulfon-amide that targets the G1 phase of the cell cycle.

More Information Supplier Page

Bedaquiline (TMC-207) 50mg 50mg  | Purity Not Available

Adooq Bioscience

TMC207 is a first-in-class diarylquinoline compound with a novel mechanism of action, the inhibition of bacterial ATP synthase, and potent activity against drug-sensitive and drug-resistant TB.

More Information Supplier Page

Lonafarnib (SCH66336) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Lonafarnib (SCH 66336) is a selectively FPTase inhibitor for H-ras, K-ras-4B and N-ras with IC50 of 1.9 nM, 5.2 nM and 2.8 nM, respectively.

More Information Supplier Page

Anamorelin 10mg 10mg  | Purity Not Available

Adooq Bioscience

Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.

More Information Supplier Page

Anamorelin HCl 5mg 5mg  | Purity Not Available

Adooq Bioscience

Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.

More Information Supplier Page